Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Income from Continuing Operations of 238300000.0 for Q1 2026, up 30.58% year-over-year from 182500000.0 in Q1 2025, and up 129.05% quarter-over-quarter from 820400000.0 in Q4 2025.
Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 238300000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 30.58% year-over-year to 238300000.0; the TTM figure through Mar 2026 stood at 197500000.0 (down 251.81% YoY), while the FY2025 annual figure was 253200000.0, down 310.3% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 238300000.0, up from 820400000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 419700000.0 in Q4 2023, with the low at 820400000.0 in Q4 2025.
- The 5-year median for Income from Continuing Operations is 182500000.0 (2025), against an average of 94100000.0.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations surged 778.03% in 2023, then tumbled 229.78% in 2024.
- Zimmer Biomet Holdings' Income from Continuing Operations stood at 47800000.0 in 2022, then surged by 778.03% to 419700000.0 in 2023, then sank by 229.78% to 544700000.0 in 2024, then tumbled by 50.62% to 820400000.0 in 2025, then jumped by 129.05% to 238300000.0 in 2026.
- Business Quant data shows ZBH's Income from Continuing Operations at 238300000.0 in Q1 2026, 820400000.0 in Q4 2025, and 231200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199.60 Mn |
| Mar 31, 2026 | 238.30 Mn |
| Dec 31, 2025 | -820.40 Mn |
| Sep 30, 2025 | 231.20 Mn |
| Jun 30, 2025 | 153.40 Mn |
| Mar 31, 2025 | 182.50 Mn |
| Dec 31, 2024 | -544.70 Mn |
| Sep 30, 2024 | 249.20 Mn |
| Jun 30, 2024 | 243.10 Mn |
| Mar 31, 2024 | 172.80 Mn |
| Dec 31, 2023 | 419.70 Mn |
| Sep 30, 2023 | 162.80 Mn |
| Jun 30, 2023 | 209.90 Mn |
| Mar 31, 2023 | 232.70 Mn |
| Dec 31, 2022 | 47.80 Mn |
| Sep 30, 2022 | 194.20 Mn |
| Jun 30, 2022 | 154.00 Mn |
| Mar 31, 2022 | 73.20 Mn |
| Dec 31, 2021 | -672.50 Mn |
| Sep 30, 2021 | 162.40 Mn |